It has become increasingly apparent that cancer patients with high plasma levels of AAT have worse prognosis (Higashiyama et al., 1992; Zelvyte et al., 2004b; Li et al., 2011) although there is no evidence to point to the specific pro-tumor effects of AAT. This evidence concerns the gene SERPINA1 and neoplasm.